持续或间歇输注的皮质类固醇在败血症休克:一个基于GRADE的系统性审查和元分析
Parinaz Sadat Mahmoudi1, Farhood Sadeghi2,3, Mehran Saberian4
1Department of Clinical Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
Journal of anesthesia, analgesia and critical care
|January 6, 2026
概括
与间歇性玻尿酸相比,持续的皮注射可能会改善败血症冲击的逆转,并减少代谢并发症,尽管死亡率仍然相似. 这一发现为重症监护管理提供了洞察力.
科学领域:
- 关键护理医学 关键护理医学
- 药理学 药理学是指药理学的学科.
- 传染性疾病 传染性疾病
背景情况:
- 败血性休克是一种危及生命的疾病,其特点是器官功能障碍和高死亡率.
- 有效的感染性休克管理策略对于改善患者的治疗结果至关重要.
研究的目的:
- 在性休克患者中全面评估连续与间歇性玻尿酸的比较效应.
- 分析主要和次要结果,包括死亡率和特定的临床参数.
主要方法:
- 在主要数据库 (PubMed,Embase,Scopus,Web of Science) 进行系统的文献搜索,截至2025年6月.
- 包括随机对照试验和依据PRISMA指南的队列研究.
- 使用已建立的框架评估偏见风险和证据确定性 (Cochrane RoB 2,ROBINS-I,GRADE).
主要成果:
- 连续和间歇性皮组之间在ICU,医院或28天死亡率上没有显著差异.
- 持续输液显示显著改善了7天的冲击逆转.
- 持续输液与降低低血和降低血糖变异性有关.
结论:
- 连续输注皮可能在治疗败血症休克方面提供特定的临床优势.
- 这些好处包括改善冲击逆转和更好的代谢控制.
- 进一步的研究可能会完善在败血症休克中最佳的皮给药策略.
相关概念视频
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
227
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
227
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
177
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
177
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
425
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
425
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
1.5K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.5K
COPD: Management Using Bronchodilators and Corticosteroids
719
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
719
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
231
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
231


